|
1
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caporali S, Falcinelli S, Starace G, et
al: DNA damage induced by temozolomide signals to both ATM and ATR:
role of the mismatch repair system. Mol Pharmacol. 66:478–491.
2004.PubMed/NCBI
|
|
4
|
Zhang J, Stevens MF and Bradshaw TD:
Temozolomide: mechanisms of action, repair and resistance. Curr Mol
Pharmacol. 5:102–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu J, Zhang X, Zhang L, et al: Skp2 E3
ligase integrates ATM activation and homologous recombination
repair by ubiquitinating NBS1. Mol Cell. 46:351–361. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andegeko Y, Moyal L, Mittelman L, Tsarfaty
I, Shiloh Y and Rotman G: Nuclear retention of ATM at sites of DNA
double strand breaks. J Biol Chem. 276:38224–38230. 2001.PubMed/NCBI
|
|
7
|
Shiloh Y and Ziv Y: The ATM protein
kinase: regulating the cellular response to genotoxic stress, and
more. Nat Rev Mol Cell Biol. 14:197–210. 2013. View Article : Google Scholar
|
|
8
|
Jiang G, Li LT, Xin Y, Zhang L, Liu YQ and
Zheng JN: Strategies to improve the killing of tumors using
temozolomide: targeting the DNA repair protein MGMT. Curr Med Chem.
19:3886–3892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skiriute D, Vaitkiene P, Saferis V, et al:
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in
glioblastoma. BMC Cancer. 12:2182012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Felsberg J, Thon N, Eigenbrod S, et al:
Promoter methylation and expression of MGMT and the DNA mismatch
repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and
recurrent glioblastomas. Int J Cancer. 129:659–670. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Natsumeda M, Aoki H, Miyahara H, et al:
Induction of autophagy in temozolomide treated malignant gliomas.
Neuropathology. 31:486–493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin CJ, Lee CC, Shih YL, et al: Inhibition
of mitochondria- and endoplasmic reticulum stress-mediated
autophagy augments temozolomide-induced apoptosis in glioma cells.
PLoS One. 7:e387062012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kabeya Y, Mizushima N, Yamamoto A,
Oshitani-Okamoto S, Ohsumi Y and Yoshimori T: LC3, GABARAP and
GATE16 localize to autophagosomal membrane depending on form-II
formation. J Cell Sci. 117:2805–2812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu J, Dang Y, Su W, et al: Molecular
cloning and characterization of rat LC3A and LC3B - two novel
markers of autophagosome. Biochem Biophys Res Commun. 339:437–442.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murrow L and Debnath J: Autophagy as a
stress-response and quality-control mechanism: implications for
cell injury and human disease. Annu Rev Pathol. 8:105–137. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paglin S, Hollister T, Delohery T, et al:
A novel response of cancer cells to radiation involves autophagy
and formation of acidic vesicles. Cancer Res. 61:439–444.
2001.PubMed/NCBI
|
|
17
|
Graf MR, Jia W and Loria RM: The
neuro-steroid, 3beta androstene 17alpha diol exhibits potent
cytotoxic effects on human malignant glioma and lymphoma cells
through different programmed cell death pathways. Br J Cancer.
97:619–627. 2007. View Article : Google Scholar
|
|
18
|
Wong PM, Puente C, Ganley IG and Jiang X:
The ULK1 complex: sensing nutrient signals for autophagy
activation. Autophagy. 9:124–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanchez AM, Csibi A, Raibon A, et al: AMPK
promotes skeletal muscle autophagy through activation of forkhead
FoxO3a and interaction with Ulk1. J Cell Biochem. 113:695–710.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leone RD and Amaravadi RK: Autophagy: a
targetable linchpin of cancer cell metabolism. Trends Endocrinol
Metab. 24:209–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheong H, Lu C, Lindsten T and Thompson
CB: Therapeutic targets in cancer cell metabolism and autophagy.
Nat Biotechnol. 30:671–678. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katayama M, Kawaguchi T, Berger MS and
Pieper RO: DNA damaging agent-induced autophagy produces a
cytoprotective adenosine triphosphate surge in malignant glioma
cells. Cell Death Differ. 14:548–558. 2007. View Article : Google Scholar
|
|
24
|
Marinoglou K: The role of the DNA damage
response kinase ataxia telangiectasia mutated in neuroprotection.
Yale J Biol Med. 85:469–480. 2012.PubMed/NCBI
|
